RedHill Biopharma Announces Fifth U.S. Patent Covering TALICIA® for H. pylori Infection

    NEXT STORY
    Hemostemix Provides Highlights of 2018 Accomplishments
    PREV STORY
    Moleculin Announces Dr. James L. Abbruzzese, Chief of Medical Oncology Division at Duke University, Joins Science Advisory Board
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Sunesis Announces Publication in “Drugs” Detailing Molecular and Pharmacologic Properties of Vosaroxin

    SOUTH SAN FRANCISCO, Calif., Aug. 25, 2016 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) ...

    author_avatar
    NASDAQ Market News

    Rockwell Medical, Inc. Reports Fourth Quarter and Full Year 2018 Financial Results

    author_avatar
    NASDAQ Market News

    MPI – FDA godkänner OVs IDE och IND för PARPi för äggstockscancerpatienter

    Hørsholm, Danmark, 27 augusti 2018 - Medical Prognosis Institute A/S (MPI) och Oncology Venture ...

    author_avatar
    NASDAQ Market News